jueves, 10 de enero de 2019

Shutdown has Aimmune waiting on FDA on multiple fronts

Shutdown has Aimmune waiting on FDA on multiple fronts

The Readout

Damian Garde



Shutdown has Aimmune waiting on FDA on multiple fronts — a sign of broader delays for biopharma

No hay comentarios: